Kristi J Smock

Summary

Affiliation: ARUP Institute for Clinical and Experimental Pathology
Country: USA

Publications

  1. doi request reprint Elevated factor IX activity is associated with an increased odds ratio for both arterial and venous thrombotic events
    Nahla M Heikal
    ARUP Laboratories, 500 Chipeta Way, Mail Stop 115 G04, Salt Lake City, UT 84108
    Am J Clin Pathol 140:680-5. 2013
  2. ncbi request reprint Laboratory identification of lupus anticoagulants
    Kristi J Smock
    ARUP Laboratories, Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA
    Am J Hematol 84:440-2. 2009
  3. doi request reprint Laboratory evaluation of clopidogrel responsiveness by platelet function and genetic methods
    Kristi J Smock
    Department of Pathology, University of Utah Health Sciences Center and ARUP Laboratories Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA
    Am J Hematol 86:1032-4. 2011
  4. doi request reprint Laboratory evaluation of aspirin responsiveness
    Kristi J Smock
    Department of Pathology, University of Utah Health Sciences Center and ARUP Laboratories, Salt Lake City, Utah, USA
    Am J Hematol 85:358-60. 2010
  5. doi request reprint Discard tubes are not necessary when drawing samples for specialized coagulation testing
    Kristi J Smock
    Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA
    Blood Coagul Fibrinolysis 21:279-82. 2010
  6. doi request reprint Effects of EDTA on routine and specialized coagulation testing and an easy method to distinguish EDTA-treated from citrated plasma samples
    Ronda A Crist
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City ARUP Hemostasis Thrombosis Laboratory, Salt Lake City, UT 84108, USA
    Lab Hematol 15:45-8. 2009
  7. doi request reprint Antiphospholipid antibody syndrome
    Nikhil A Sangle
    Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Arch Pathol Lab Med 135:1092-6. 2011
  8. doi request reprint Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice
    Ryan Wilcox
    Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, UT, USA
    Hosp Pract (1995) 39:23-34. 2011
  9. ncbi request reprint Assessment of orally dosed commercial silver nanoparticles on human ex vivo platelet aggregation
    Kristi J Smock
    Department of Pathology and ARUP Laboratories Institute for Clinical and Experimental Pathology, Health Sciences, University of Utah, Salt Lake City, Utah, UT 84112, USA
    Nanotoxicology 8:328-33. 2014
  10. doi request reprint Laboratory testing for platelet antibodies
    Nahla M Heikal
    Department of Pathology, University of Utah Health Sciences Center, and ARUP Laboratories Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Am J Hematol 88:818-21. 2013

Collaborators

Detail Information

Publications14

  1. doi request reprint Elevated factor IX activity is associated with an increased odds ratio for both arterial and venous thrombotic events
    Nahla M Heikal
    ARUP Laboratories, 500 Chipeta Way, Mail Stop 115 G04, Salt Lake City, UT 84108
    Am J Clin Pathol 140:680-5. 2013
    ..We retrospectively sought to determine whether elevated FIX levels are a risk factor for thrombosis in 81 adult subjects younger than 65 years (mean, 47 years) who were referred for evaluation of a hypercoagulable state...
  2. ncbi request reprint Laboratory identification of lupus anticoagulants
    Kristi J Smock
    ARUP Laboratories, Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA
    Am J Hematol 84:440-2. 2009
    ..This article summarizes laboratory testing for LAs, with particular focus on technical issues and limitations of testing. Am. J. Hematol. 2009. (c) 2009 Wiley-Liss, Inc...
  3. doi request reprint Laboratory evaluation of clopidogrel responsiveness by platelet function and genetic methods
    Kristi J Smock
    Department of Pathology, University of Utah Health Sciences Center and ARUP Laboratories Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA
    Am J Hematol 86:1032-4. 2011
    ..This article summarizes the currently available laboratory testing, including platelet function tests and genotyping for CYP2C19 variants...
  4. doi request reprint Laboratory evaluation of aspirin responsiveness
    Kristi J Smock
    Department of Pathology, University of Utah Health Sciences Center and ARUP Laboratories, Salt Lake City, Utah, USA
    Am J Hematol 85:358-60. 2010
    ..This article summarizes available laboratory testing of aspirin response with focus on technical issues, limitations, and current opinion on the utility of routine patient testing...
  5. doi request reprint Discard tubes are not necessary when drawing samples for specialized coagulation testing
    Kristi J Smock
    Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA
    Blood Coagul Fibrinolysis 21:279-82. 2010
    ..Our data suggest that discard tubes are not necessary when drawing samples for specialized coagulation testing...
  6. doi request reprint Effects of EDTA on routine and specialized coagulation testing and an easy method to distinguish EDTA-treated from citrated plasma samples
    Ronda A Crist
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City ARUP Hemostasis Thrombosis Laboratory, Salt Lake City, UT 84108, USA
    Lab Hematol 15:45-8. 2009
    ..We confirm that EDTA has effects on coagulation assays. Sodium tetraphenylborate testing is a quick, simple, and inexpensive method for coagulation laboratories to identify samples erroneously submitted in EDTA...
  7. doi request reprint Antiphospholipid antibody syndrome
    Nikhil A Sangle
    Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Arch Pathol Lab Med 135:1092-6. 2011
    ..This review discusses the key laboratory and clinical aspects of antiphospholipid antibody syndrome. Particular focus is given to lupus anticoagulant detection, in view of recently updated laboratory guidelines...
  8. doi request reprint Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice
    Ryan Wilcox
    Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, UT, USA
    Hosp Pract (1995) 39:23-34. 2011
    ..We also provide an approach to patients on dabigatran etexilate who are bleeding, have a suspected therapeutic failure, or require periprocedural management...
  9. ncbi request reprint Assessment of orally dosed commercial silver nanoparticles on human ex vivo platelet aggregation
    Kristi J Smock
    Department of Pathology and ARUP Laboratories Institute for Clinical and Experimental Pathology, Health Sciences, University of Utah, Salt Lake City, Utah, UT 84112, USA
    Nanotoxicology 8:328-33. 2014
    ..e., active and placebo solutions). Enhanced ex vivo platelet activation was not detectable at peak serum silver concentrations <10 µg/L. Further studies of colloidal silver nanoparticles on human platelet activities are warranted...
  10. doi request reprint Laboratory testing for platelet antibodies
    Nahla M Heikal
    Department of Pathology, University of Utah Health Sciences Center, and ARUP Laboratories Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Am J Hematol 88:818-21. 2013
    ....
  11. doi request reprint Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer
    Brian H Shirts
    Department of Pathology, University of Utah Medical Center, Salt Lake City, UT 84124, USA
    Thromb Res 130:e134-8. 2012
    ..Prothrombin G20210A (PT20210) carriers have increased prothrombin levels and increased risk for venous thrombosis. We hypothesized PT20210 carriers would have decreased PT, aPTT, and dRVVT clotting times...
  12. doi request reprint Prevalence of heparin in samples submitted for lupus anticoagulant testing
    Nikhil A Sangle
    Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Lab Hematol 17:6-11. 2011
    ..We searched our reference laboratory database to determine the prevalence of heparin in samples submitted for LA testing...
  13. doi request reprint Diffuse large B-cell lymphoma with aberrant expression of the T-cell antigens CD2 and CD7
    Nikhil A Sangle
    Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Appl Immunohistochem Mol Morphol 19:579-83. 2011
    ..Recognition of these types of cases is important to help ensure accurate diagnoses are made...
  14. doi request reprint An inherited disorder with splenomegaly, cytopenias, and vision loss
    Srinivas K Tantravahi
    Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Am J Med Genet A 158:475-81. 2012
    ..Despite numerous medical and ophthalmic evaluations, no diagnosis has been discovered...